Your search returned over 250 studies. The top 250 studies are being displayed. Please use additional keywords or decrease the search distance. Get alerts for new studies
- Dose Escalation Study for Primary Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular
1 Location available
- Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Conditions: Stage III Squamous Cell Carcinoma of the Hypopharynx - Stage III Squamous Cell Carcinoma of the Larynx - Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity - Stage III Squamous Cell Carcinoma of the Nasopharynx - Stage III Squamous Cell Carcinom
9 Locations available
- Dendritic Cell Vaccine for Head and Neck Cancer
Conditions: Squamous Cell Carcinoma of Head and Neck
1 Location available
- Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck - Basaloid Squamous Cell Carcinoma - Undifferentiated Carcinoma - Adenosquamous Cell Carcinoma
1 Location available
- Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma
6 Locations available
- Sexual Behavior in Head and Neck Cancer Patients
Conditions: Oropharyngeal Cancer - Head and Neck Cancer - Squamous Cell Carcinoma
1 Location available
- Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma - Renal Cancer
2 Locations available
- A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®
Conditions: Liver Tumors - Hepatocellular Carcinoma - Hepatoma - Neoplasms
1 Location available
- Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
1 Location available
- Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer
Conditions: Renal Cell Carcinoma - Graft-Versus-Host Disease - Engraftment Syndrome
2 Locations available
- Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
Conditions: Hepatocellular Carcinoma
1 Location available
- A Study of Erlotinib Plus Radiotherapy (RT) for Patients With Advanced or Inoperable Non-Small-Cell Lung Cancer
Conditions: Carcinoma, Non-small-cell Lung
2 Locations available
- Magnetic Resonance Imaging (MRI) in the Assessment of Head and Neck Squamous Cell Carcinoma (HNSCC) Response
Conditions: Head and Neck Cancer
1 Location available
- A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer
Conditions: Melanoma - Carcinoma, Renal Cell
1 Location available
- Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer
Conditions: Renal Cell Carcinoma - Stage III Renal Cell Cancer - Stage IV Renal Cell Cancer
1 Location available
- PD 0332991 in Treating Patients With Refractory Solid Tumors
Conditions: Adult Solid Tumor - Adenocarcinoma of the Colon - Adenocarcinoma of the Rectum - Adult Central Nervous System Germ Cell Tumor - Adult Teratoma - Benign Teratoma - Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - Famili
1 Location available
- Phase II Study of RAD001 Head and Neck Cancer
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Conditions: Ovarian Cancer - Non Small Cell Lung Cancer - Prostate Cancer - Colorectal Cancer - Gastric Cancer - Esophageal Cancer - Cancer of Head and Neck
23 Locations available
- Dalteparin in Combination With Sunitinib in Patients With Metastatic Kidney Cancer
Conditions: Renal Cell Carcinoma
2 Locations available
- Docetaxel And Cisplatin With or Without Erlotinib For Metastatic Or Recurrent Squamous Cell Carcinoma Of Head And Neck
Conditions: Head and Neck Cancer - Squamous Cell Carcinoma of the Head and Neck
1 Location available
- MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Metabolomic Analysis of Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung - Carcinoma, Small Cell Lung
1 Location available
- Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Conditions: Carcinomas (Including Squamous Cell and Adenocarcinoma) - Neoplasms
1 Location available
- Identification of Key Blood Molecular Markers for Immunotherapy
Conditions: Squamous Cell Carcinoma - Adenocarcinoma - Neoplasms
1 Location available
- RAD001 in Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
3 Locations available
- Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma - Liver Cancer - Hepatoma
1 Location available
- A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer
Conditions: Carcinoma, Squamous Cell
1 Location available
- Everolimus(RAD001) For Advanced Renal Cell Carcinoma(RCC)Before Kidney Removal
Conditions: Kidney Cancer
2 Locations available
- Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma
Conditions: Carcinoma, Squamous Cell
1 Location available
- TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma - Liver Cancer - Liver Neoplasm - Primary Liver Cancer
1 Location available
- A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers
Conditions: Small Cell Lung Carcinoma - Malignant Epithelial Neoplasms
1 Location available
- Preoperative Treatment With Cetuximab and/or IMC-A12
Conditions: Head and Neck Squamous Cell Carcinoma
1 Location available
- A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
5 Locations available
- A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung
Conditions: Carcinoma
8 Locations available
- BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
24 Locations available
- MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies
Conditions: Advanced Nonhematological Malignancies - Non-Small Cell Lung Cancer - Small Cell Lung Cancer - Metastatic Breast Cancer - Head and Neck Squamous Cell Carcinoma - Gastroesophageal Adenocarcinoma
3 Locations available
- Vorinostat, Cisplatin, and Radiation Therapy in Treating Patients With Stage III or Stage IV Squamous Cell Cancer of the Oropharynx
Conditions: Stage III Squamous Cell Carcinoma of the Oropharynx - Stage IV Squamous Cell Carcinoma of the Oropharynx
1 Location available
- Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx
Conditions: Squamous Cell Carcinoma of Oropharynx
1 Location available
- Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas
Conditions: Skin Cancers - Carcinoma, Basal Cell - Skin Cancer - Basal Cell Carcinoma
1 Location available
- Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy
Conditions: Adenocarcinoma of the Esophagus - Adenocarcinomas of the Gastroesophageal Junction - Recurrent Esophageal Cancer - Squamous Cell Carcinoma of the Esophagus - Stage IV Esophageal Cancer
1 Location available
- Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophage
Conditions: Lung Cancer - Esophageal Cancer - Malignant Pleural Mesothelioma - Thymoma - Thymic Carcinoma
1 Location available
- Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy
Conditions: Liver Cancer
1 Location available
- Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
Conditions: Liver Cancer
1 Location available
- Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo.
Conditions: Basal Cell Carcinoma - Melanoma - Squamous Cell Carcinoma - Non-Malignant Skin Disorders
1 Location available
- A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
Conditions: Hedgehog Pathway - Smoothened - Basal Cell Carcinoma (BCC) - Basal Cell Nevoid Syndrome (BCNS)
2 Locations available
- A Phase 1b Study of MDX-1106 in Subjects With Advanced or Recurrent Malignancies
Conditions: Metastatic Castration-resistant Prostrate Cancer (mCRPC) - Renal Cell Carcinoma (RCC) - Metastatic Melanoma (MEL) - Non-small Cell Lung Cancer (NSCLC)
10 Locations available
- Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer
Conditions: Carcinoma, Renal Cell
1 Location available
- Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC)
Conditions: Head and Neck Cancer
2 Locations available
- A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer
Conditions: Small Cell Lung Carcinoma
2 Locations available
- Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer
Conditions: Carcinoma, Non Small Cell Lung
1 Location available
- Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma - Liver Cancer
1 Location available
- Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
2 Locations available
- Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or
Conditions: Squamous Cell Carcinoma
1 Location available
- Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer
Conditions: Squamous Cell Carcinoma - Laryngeal Cancer
1 Location available
- A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer
Conditions: Renal Cell Carcinoma - Pharmacokinetics of AGS-16M8F
3 Locations available
- Randomized Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck
Conditions: Head and Neck Cancer
1 Location available
- Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
Conditions: Neuroendocrine Tumors - Brain (Nervous System) Cancers - Colon/Rectal Cancer - Colon Cancer - Hepatobiliary Cancers - Hepatocellular Carcinoma (Hepatoma) - Liver
1 Location available
- Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract
Conditions: Upper Aerodigestive Tract Lesions - Neoplasms, Oropharyngeal - Oropharyngeal Cancer - Neoplasms, Hypopharyngeal - Hypopharyngeal Cancer - Head and Neck Neoplasms - UADT Neoplasms - Carcinoma, Squamous Cell - Papilloma
1 Location available
- Humanitarian Device Exemption (HDE) Treatment Protocol
Conditions: Carcinoma, Hepatocellular - Liver Cancer
1 Location available
- Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma
9 Locations available
- A Study in Non-Small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma
3 Locations available
- A Phase II Study of RT Concurrent With Cetuximab in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Do Not Qualify For Standa
Conditions: Squamous Cell Carcinoma of the Larynx, Hypopharynx, Oropharynx, or Oral Cavity. - The Patients Will be Limited to Age 70 and Older, - OR w/ Co-morbidities Precluding Treatment With Chemotherapy
1 Location available
- An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
Conditions: Carcinoma, Non-Small-Cell Lung - Head and Neck Neoplasms
4 Locations available
- Safety Study of Modified Vaccinia Virus to Cancer
Conditions: Melanoma - Breast Cancer - Head and Neck Squamous Cell Cancer - Liver Cancer - Colorectal Cancer - Pancreatic Adenocarcinoma
1 Location available
- Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RADOO1
Conditions: Kidney Neoplasms - Kidney (Renal Cell) Cancer
1 Location available
- Trial of Second Generation Designer T Cells in Colorectal Carcinoma
Conditions: Colorectal Cancer
1 Location available
- Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer
Conditions: Advanced Metastatic Carcinoma
1 Location available
- Four Doses of MAGE Vaccine for Patients With Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma - Head and Neck Cancer
1 Location available
- Microwave Ablation of Resectable Liver Tumors
Conditions: Hepatocellular Carcinoma - Liver Cancer
1 Location available
- Computed Tomography (CT) Perfusion Imaging of Lung Cancer
Conditions: Carcinoma, Non Small Cell Lung
4 Locations available
- Image-Guided Adaptive Conformal Photon Versus Proton Therapy
Conditions: Non-Small-Cell Lung Carcinoma
2 Locations available
- Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
1 Location available
- A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
2 Locations available
- Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma
Conditions: Head And Neck Cancer
1 Location available
- Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma
Conditions: Liver Cancer
3 Locations available
- Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Conditions: Refractory Head and Neck Cancer, Squamous Cell Carcinoma of the Skin, Carcinoma of the Breast, and Malignant Melanoma
4 Locations available
- Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck
Conditions: Head and Neck Cancer - Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - R
1 Location available
- Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma
Conditions: Metastatic Renal Cell Carcinoma
3 Locations available
- Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myelom
Conditions: Multiple Myeloma - Diffuse Large B-Cell Lymphoma - Glioblastoma Multiforme - Hepatocellular Carcinoma - Non-Small Cell Lung Cancer - Gastrointestinal Neuroendocrine Tumors of Non-Pancreatic Origin - Hormone Receptor-Positive Breast Cancer
8 Locations available
- Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life
Conditions: Squamous Cell Carcinoma of the Oropharynx
1 Location available
- Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma - Liver Cancer - Adrenal Cancer
2 Locations available
- Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention
Conditions: Oral Squamous Cell Carcinoma - Oral Epithelial Dysplasia
3 Locations available
- Comparison of Elective Lymph Node Treatment Versus Clinical Observation in the Absence of Palpable Lymph Nodes for High Risk Skin Squamous Cell Carcin
Conditions: High Risk Cutaneous Squamous Cell Carcinoma
1 Location available
- IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma
Conditions: Metastatic Renal Cell Carcinoma
18 Locations available
- Treatment of Patients With Advanced Renal Cancer With a Radio-labeled Antibody, Yttrium-90 Conjugated Chimeric G250
Conditions: Renal Cell Carcinoma - Kidney Neoplasm - Renal Cancer - Kidney Cancer
1 Location available
- Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
Conditions: Carcinoma, Giant Cell - Carcinoma, Non-Small-Cell Lung - Lung Cancer
1 Location available
- Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Pat
Conditions: Carcinoma, Squamous Cell
1 Location available
- Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Conditions: Lung Neoplasm - Carcinoma Non-small Cell Lung Cancer Stage IIIA - Carcinoma Non-small Cell Lung Cancer Stage IIIB - Carcinoma Non-small Cell Lung Cancer Stage IV
50 Locations available
- TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma
1 Location available
- Induction Therapy-Docetaxel, Cisplatin and Fluorouracil in Untreated Advanced Squamous Cell or Undifferentiated Carcinoma of the Paranasal Sinuses
Conditions: Paranasal Sinuses - Squamous Cell Carcinoma
1 Location available
- Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors
Conditions: Cancer - Non-Small Cell Lung Cancer - Endometrial Carcinoma - Ovarian Carcinoma
3 Locations available
- Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocelluar Carcinoma
Conditions: Liver Cancer - Hepatitis B - Hepatitis C - Hepatobiliary Cancers Liver - Hepatobiliary Cancers
1 Location available
- Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin for Non-Small Cell Lung Cancer With KRAS or EGFR Activation
Conditions: Carcinoma, Non-small Cell Lung
5 Locations available
- Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC
Conditions: Hepatocellular Carcinoma
10 Locations available
- An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The
Conditions: Carcinoma, Non-Small-Cell Lung
13 Locations available
- An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gen
Conditions: Carcinoma, Non-Small-Cell Lung
4 Locations available
- Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-
Conditions: Renal Cell Carcinoma - Non-hodgkin's Lymphoma
5 Locations available
- Cure Rates of Superficial Basal Cell Carcinom (BCC) Following 1 Versus 3 Cycles of Electrodessication and Curettage (ED&C)
Conditions: Superficial Basal Cell Carcinoma
1 Location available
- A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy in Patients With Advanced Non-Small Cell Lung Carcinoma (NSCLC)
Conditions: Non-Small Cell Lung Cancer
2 Locations available
- A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Patients With Hepa
Conditions: Hepatocellular Carcinoma
19 Locations available
- Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
2 Locations available
- Paclitaxel, Carboplatin and Cetuximab (PCC) Versus Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Loca
Conditions: Head and Neck Squamous Cell Carcinoma
2 Locations available
- Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
Conditions: Carcinoma, Squamous Cell of the Head and Neck
25 Locations available
- Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Sub
Conditions: Bladder Neoplasm - Intravesical Drug Administration - Neoplasm Recurrence, Local - Transitional Cell, Carcinoma - Carcinoma in Situ - Mycobacterium
56 Locations available
- Genetic Study of Patients With Inherited Urologic Malignancies
Conditions: Birt Hogg Dube Syndrome - Hereditary Papillary Renal Cell Carcinoma - Kidney Cancer - Multiple Endocrine Neoplasia - Von Hippel-Lindau Syndrome
1 Location available
- Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma
Conditions: Liver Cancer
3 Locations available
- Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Conditions: Hereditary Clear Cell Renal Cell Carcinoma - Kidney Cancer
1 Location available
- PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
Conditions: Carcinoma, Non-small Cell
6 Locations available
- Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular
1 Location available
- A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract
Conditions: Head and Neck Squamous Cell Carcinoma
1 Location available
- A Pilot for a Case-Control Study of Esophageal Squamous Cell Carcinoma in Western Kenya
Conditions: Esophageal Neoplasms
1 Location available
- A Clinical Study of GP73 as a Hepatocellular Carcinoma (HCC) Tumor Mark
Conditions: Hepatocellular Carcinoma
1 Location available
- Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients
Conditions: Metastatic Renal Cell Carcinoma
1 Location available
- Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer
Conditions: Renal Cell Carcinoma
1 Location available
- A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancie
Conditions: Renal Cell Carcinoma - Breast Cancer - Colon Cancer - Lung Cancer - Non-Hodgkin Lymphoma
3 Locations available
- Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetax
Conditions: Non-small Cell Lung Cancer
4 Locations available
- Siliphos in Advanced Hepatocellular Carcinoma
Conditions: Advanced Hepatocellular Carcinoma
1 Location available
- Proton Beam Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With Hepatocellular Carcinoma Exceeding San Francisco Criteria
Conditions: Carcinoma, Hepatocellular
1 Location available
- Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma - Recurrent Renal Cell Cancer - Stage IV Renal Cell Cancer
2 Locations available
- A Phase II Study Using Short-Term Cultured, CD8+-Enriched Autologous Tumor-infiltrating Lymphocytes Following a Lymphocyte Depleting Regimen in Metast
Conditions: Metastatic Colorectal Cancer - Metastatic Gastric Cancer - Metastatic Pancreatic Cancer - Metastatic Hepatocellular Carcinoma - Metastatic Cholangiocarcinoma
1 Location available
- ABT-888 and Temozolomide for Liver Cancer
Conditions: Hepatocellular Carcinoma
1 Location available
- A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma (HCC)
1 Location available
- Phase 1 and 2 Study of PX-866 and Cetuximab
Conditions: Incurable Metastatic Colorectal Carcinoma - Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
31 Locations available
- Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma
7 Locations available
- Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer
Conditions: Basal Cell Carcinoma of the Skin - Pain - Recurrent Skin Cancer
1 Location available
- A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
Conditions: Basal Cell Carcinoma
24 Locations available
- E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
Conditions: Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
5 Locations available
- Phase III of Unilateral Neck Irradiation With Amifostine in Patients With SCC of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
Conditions: Kidney Neoplasms - Carcinoma, Renal Cell - Kidney (Renal Cell) Cancer
1 Location available
- Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI
Conditions: Hepatocellular Carcinoma
1 Location available
- Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma - Neoplasm Metastases
3 Locations available
- Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium
Conditions: Bladder Cancer
1 Location available
- A Study of IMC-A12 in Combination With Sorafenib in Patients With Advanced Cancer of the Liver
Conditions: Hepatocellular Carcinoma
7 Locations available
- Electronic Brachytherapy for the Treatment of NMSC
Conditions: Basal Cell Carcinoma - Squamous Cell Carcinoma
5 Locations available
- Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular
Conditions: Carcinoma
6 Locations available
- Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors
Conditions: Pancreatic Cancer - Liver Cancer - Lung Cancer - Lung Cancer Non-Small Cell Cancer (NSCLC) - Lung Cancer Small Cell Lung Cancer (SCLC) - Hepatobiliary Cancers - Hepatobiliary Cancers Liver - Hepatobiliary Cancers Hepatocellular Carcinoma (Hepatoma) - Hepa
1 Location available
- A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Recurrent or Refractory Medulloblastoma - Locally Advanced or Metastatic Basal Cell Carcinoma
2 Locations available
- Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery
Conditions: Recurrent Bladder Cancer - Stage 0 Bladder Cancer - Stage I Bladder Cancer - Stage II Bladder Cancer - Transitional Cell Carcinoma of the Bladder
1 Location available
- A Phase I Study of Ridaforolimus and Vorinostat in Patients With Advanced Renal Cell Carcinoma (RCC)
Conditions: Advanced Renal Cell Carcinoma
1 Location available
- Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma
Conditions: Kidney Cancer
1 Location available
- Study of Erlotinib in the Treatment of Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC) of the Skin
Conditions: Skin Cancer
1 Location available
- Study of PX-866 and Docetaxel in Solid Tumors
Conditions: Non Small Cell Lung Cancer (NSCLC) - Squamous Cell Carcinoma of the Head and Neck (SCCHN)
28 Locations available
- Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery
Conditions: Acinar Cell Carcinoma of Pancreas - Duct Cell Adenocarcinoma of the Pancreas - Pancreatic Carcinoma Recurrent - Stage IA Pancreatic Cancer - Stage IB Pancreatic Cancer - Stage IIA Pancreatic Cancer - Stage IIB Pancreatic Cancer - Pancreatic Carcinoma Stag
17 Locations available
- A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck (SCCHN)
1 Location available
- ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy
Conditions: Hepatocellular Carcinoma
6 Locations available
- Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium
Conditions: Squamous Cell Carcinoma of the Oral Cavity - Oropharynx - Larynx - Hypopharynx
1 Location available
- Stereotactic Body Radiotherapy for Liver Tumors
Conditions: Liver Metastases - Hepatocellular Carcinoma - Intrahepatic Cholangiocarcinoma
1 Location available
- TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
1 Location available
- Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma
Conditions: Advanced Non-clear Cell Renal Cell Carcinoma
9 Locations available
- Safety Study of MGAH22 in HER2-positive Carcinomas
Conditions: Breast Cancer - Gastric Cancer - Bladder Cancer - Ovarian Cancer - Non-small Cell Lung Cancer
2 Locations available
- Sunitinib Malate in Treating Patients With Previously Untreated Metastatic Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma - Stage IV Renal Cell Cancer
1 Location available
- A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449) in Operable Basal Cell Carcinoma (BCC)
Conditions: Basal Cell Carcinoma
6 Locations available
- Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
12 Locations available
- Brivanib Metastatic Renal Cell Carcinoma
Conditions: Male and Female Subjects 18 Years of Age and Older With Metastatic Renal Cell Carcinoma. Eligible Patients Must Have Undergone and Failed Prior Treatment.
1 Location available
- Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer
Conditions: Recurrent Adenoid Cystic Carcinoma of the Oral Cavity - Recurrent Lymphoepithelioma of the Nasopharynx - Recurrent Lymphoepithelioma of the Oropharynx - Recurrent Mucoepidermoid Carcinoma of the Oral Cavity - Recurrent Squamous Cell Carcinoma of the Hypop
1 Location available
- Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung - Non-small Cell Lung Cancer
1 Location available
- Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity
Conditions: Squamous Cell Carcinoma (SCC) of the Oral Cavity - Squamous Cell Carcinoma of the Soft Palate
2 Locations available
- E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Patients With Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
5 Locations available
- Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and Neck
Conditions: Head and Neck Cancer
1 Location available
- Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
1 Location available
- Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small
Conditions: Anemia - Carcinoma, Non-Small-Cell Lung - Carcinoma, Small-Cell Lung - Bladder Cancer - Cancer of Head and Neck - Uterine Cervical Cancer
39 Locations available
- Circulating Tumor Cells (CTCs): A Potential Screening Test for Clinically Undetectable Breast Carcinoma
Conditions: Breast Abnormality
1 Location available
- A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Conditions: Transitional Cell Carcinoma of Bladder - Urethra Cancer - Ureter Cancer - Malignant Tumor of Renal Pelvis
7 Locations available
- Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular
1 Location available
- Phase I Biomarker Study (BMS-936558)
Conditions: Renal Cell Carcinoma
10 Locations available
- Neoadjuvant Pazopanib in Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
2 Locations available
- A Study of LY2510924 in Patients With Extensive-Stage Small Cell Lung Carcinoma
Conditions: Extensive Stage Small Cell Lung Carcinoma
10 Locations available
- Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Conditions: Recurrent Adenoid Cystic Carcinoma of the Oral Cavity - Recurrent Mucoepidermoid Carcinoma of the Oral Cavity - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell Carcinoma of the Larynx - Recurrent Squamous Cell Carcinoma of t
1 Location available
- MEDI-573 in Combination With SOC in Unresectable or Metastatic HCC.
Conditions: Unresectable or Metastatic Hepatocellular Carcinoma (HCC)
5 Locations available
- Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC
Conditions: Salivary Gland Squamous Cell Carcinoma - Stage II Salivary Gland Cancer - Stage II Squamous Cell Carcinoma of the Hypopharynx - Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity - Stage II Squamous Cell Carcinoma of the Oropharynx - Stage II Ver
1 Location available
- Study of MK-3475 in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475
Conditions: Cancer, Solid Tumor
13 Locations available
- A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
20 Locations available
- TRC105 for Liver Cancer That Has Not Responded to Sorafenib
Conditions: Hepatocellular Carcinoma - Hepatocellular Cancer - Carcinoma, Hepatocellular
1 Location available
- A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma
Conditions: Metastatic Clear Cell Renal Cell Carcinoma
18 Locations available
- Amatuximab for High Mesothelin Cancers
Conditions: Carcinoma, Pancreatic Ductal - Mesothelioma - Ovarian Neoplasms - Carcinoma, Non-Small-Cell Lung
1 Location available
- PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Conditions: Metastatic Renal Cell Carcinoma - Metastatic Melanoma
2 Locations available
- PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine
Conditions: Renal Cell Carcinoma
1 Location available
- A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
Conditions: Advanced Malignancies - Carcinoma, Non-Small-Cell Lung - Anaplastic Large Cell Lymphoma - Diffuse Large Cell Lymphoma - Inflammatory Myofibroblastic Tumors
6 Locations available
- Study of ACE-041 in Patients With Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck
2 Locations available
- Comparing Lipiodol/Ethanol With Drug-eluting Beads (DEB) for Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
1 Location available
- Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors
Conditions: Basal Cell Carcinoma
1 Location available
- De-intensification of Radiation and Chemotherapy for Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma
Conditions: Carcinoma, Squamous Cell - Head and Neck Neoplasms - Oropharyngeal Neoplasms
1 Location available
- Trial Comparing the Effects of Intermittent Vismodegib Versus Photodynamic Therapy in Patients With Multiple Basal Cell Carcinomas
Conditions: Basal Cell Nevus Syndrome - Gorlin's Syndrome
1 Location available
- Intensity-Modulated Radiation Therapy, Pemetrexed Disodium, and Erlotinib Hydrochloride in Treating Patients With Recurrent or Second Primary Head and
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell Carcinoma of the Larynx - Recurren
2 Locations available
- Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Conditions: Metastatic Renal Cell Carcinoma
40 Locations available
- Renal Cell Carcinoma (RCC) Scramble
Conditions: Renal Cell Carcinoma
1 Location available
- AMG 102 and Erlotinib for Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
1 Location available
- A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Conditions: Renal Cell Carcinoma - Cancer
47 Locations available
- A Study of LY2157299 in Patients With Hepatocellular Carcinoma
Conditions: Carcinoma - Hepatocellular
6 Locations available
- The LC Bead Trial; Transarterial Chemoembolization of Hepatocellular Carcinoma (HCC)With a Drug-eluting Bead
Conditions: Hepatocellular Carcinoma
1 Location available
- Trial of Microdosing Carboplatin
Conditions: Carcinoma, Non-Small-Cell Lung - Urinary Bladder Neoplasms
1 Location available
- Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer
Conditions: Hepatocellular Carcinoma - Liver Cancer
1 Location available
- Cabazitaxel - PF Induction Chemotherapy
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- PF-04856884 (CVX-060) In Combination With Axitinib In Patients With Previously Treated Metastatic Renal Cell Carcinoma
Conditions: Metastatic Renal Cell Carcinoma
33 Locations available
- Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Metastatic Breast Cancer - Metastatic Renal Cell Carcinoma
1 Location available
- Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma
Conditions: Squamous Cell Carcinoma Of The Head And Neck
1 Location available
- A Randomized Phase II Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.
Conditions: Patients Must Have Histologically or Cytologically Confirmed Non-squamous Cell, Non Small Cell Carcinoma of the Lung. - Patient Must Have Measurable Stage IV Disease (Includes M1a, M1b Stages or Recurrent Disease).
1 Location available
- Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC)
Conditions: Kidney Cancer
1 Location available
- Absorbable Suture Versus Tissue Glue to Repair Defects Following Mohs Surgery
Conditions: Basal Cell Carcinoma - Squamous Cell Carcinoma
1 Location available
- Sorafenib and TRC105 in Hepatocellular Cancer
Conditions: Hepatoma - Liver Neoplasms - Adenoma, Liver Cell - Carcinoma, Hepatocellular
1 Location available
- Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors
Conditions: Ewing's Sarcoma - Osteosarcoma - Astrocytoma - Atypical Teratoid/Rhabdoid Tumor - Ependymoma - Germ Cell Tumor - Glioma - Medulloblastoma - Rhabdoid Tumor - Retinoblastoma - Clear Cell Sarcoma - Renal Cell Carcinoma - Wilms Tumor - Hepatoblastoma - Neurob
1 Location available
- TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
1 Location available
- A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer
Conditions: Advanced Hepatocellular Carcinoma - HCC - Liver Cancer
1 Location available
- Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix
Conditions: Cervical Squamous Cell Carcinoma - Adenosquamous Carcinoma - Adenocarcinoma - Locally Advanced Malignant Neoplasm - Cervical Cancer
1 Location available
- Cardiovascular Effects of Sunitinib Therapy (CREST)
Conditions: Patients With Renal Cell Carcinoma Who Are Newly Initiating Therapy - With the Oral Tyrosine-kinase Inhibitor Sunitinib.
1 Location available
- Molecular Analysis of Thoracic Malignancies
Conditions: Thymus Cancer - Thymoma - Thymic Carcinoma - Lung Cancer - Carcinoma, Non-Small-Cell Lung - Mesothelioma
1 Location available
- Study of DCA (Dichloroacetate) in Combination With Cisplatin and Definitive Radiation in Head and Neck Carcinoma
Conditions: Squamous Cell Carcinoma of the Head and Neck
2 Locations available
- Association Between Hepatitis C Infection and Renal Cell Carcinoma
Conditions: Hepatitis C - Renal Cell Carcinoma - Colorectal Cancer
1 Location available
- Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
Conditions: Pancreatic Alpha Cell Carcinoma - Pancreatic Beta Islet Cell Carcinoma - Pancreatic Delta Cell Carcinoma - Pancreatic G-cell Carcinoma - Recurrent Islet Cell Carcinoma
1 Location available
- Method Development and Assessment of the Effects of Tobacco Products on Oral Cavity Cells
Conditions: Squamous Cell Carcinoma
2 Locations available
- AMG 172 First in Human Study in Patients With Kidney Cancer
Conditions: Renal Cell Adenocarcinoma - Clear Cell Renal Carcinoma - Clear Cell Renal Cell Carcinoma - Renal Cell Carcinoma
3 Locations available
- Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer
Conditions: Unresectable Hepatocellular Carcinoma
2 Locations available
- An Open-Label Study to Explore the Clinical Efficacy of GS 7977 With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recur
Conditions: Hepatitis C - Hepatocellular Carcinoma
1 Location available
- Temsirolimus as Second-line Therapy in HCC
Conditions: Unresectable or Metastatic Hepatocellular Carcinoma
1 Location available
- Bevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer
Conditions: Carcinoma, Squamous Cell of Head and Neck
1 Location available
- Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib M
Conditions: Clear Cell Renal Cell Carcinoma - Recurrent Renal Cell Cancer - Stage III Renal Cell Cancer - Stage IV Renal Cell Cancer
3 Locations available
- Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Sunitinib In Patients With Metastatic Renal Cell Carcinoma
Conditions: Renal Cancer
1 Location available
- Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy
Conditions: Adenoid Cystic Carcinoma - Squamous Cell Carcinoma - Sinonasal Carcinoma - Sinonasal Undifferentiated Carcinoma
1 Location available
- Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
1 Location available
- Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
Conditions: Head and Neck Cancer - Oropharyngeal Cancer - Human Papillomavirus - Squamous Cell Cancer
1 Location available
- Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)
Conditions: Renal Cell Carcinoma
1 Location available
- -02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung - Adenocarcinoma - Carcinoma, Squamous Cell - Carcinoma, Large Cell
1 Location available
- Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum
Conditions: Carcinoma, Small Cell - Carcinoma, Non-small-cell Lung - Esophageal Neoplasms - Mesothelioma
1 Location available
- Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinu
Conditions: Small Cell Lung Carcinoma
23 Locations available
- Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Salivary Gland Squamous Cell Carcinoma - Stage 0 Hypopharyngeal Cancer - Stage 0 Laryngeal Cancer - Stage 0 Lip and Oral Cavity Cancer - Stage 0 Nasopharyngeal Cancer - Stage 0
1 Location available
- Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer
Conditions: Head and Neck Squamous Cell Carcinoma
1 Location available
- Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma
Conditions: Pancreatic Adenocarcinoma
1 Location available
- BMS-936558 (MDX-1106) In Combination With Sunitinib or Pazopanib in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Conditions: Renal Cell Carcinoma - Clear-cell Metastatic Renal Cell Carcinoma
5 Locations available
- KD019 Versus Erlotinib in Subjects With Stage IIIB/IV Non Small Cell Lung Cancer With Progression After First- or Second-Line Chemotherapy
Conditions: Carcinoma, Non-Small-Cell Lung
1 Location available
- Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
Conditions: Adult Anaplastic Astrocytoma - Adult Anaplastic Oligodendroglioma - Adult Giant Cell Glioblastoma - Adult Glioblastoma - Adult Gliosarcoma - Adult Mixed Glioma - Adult Primary Hepatocellular Carcinoma - Chondrosarcoma - Clear Cell Sarcoma of the Kidney -
1 Location available
- Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer
Conditions: Melanoma - Merkel Cell Carcinoma - Squamous Cell Carcinoma - Penile Carcinoma - Urethral Carcinoma - Extramammary Paget's Disease - Scrotal Carcinoma - Anal Cancer - Vulvar Cancer - Skin Cancer - Lymphadenopathy
1 Location available
- Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery
Conditions: Acinar Cell Adenocarcinoma of the Pancreas - Duct Cell Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network
Conditions: Non-small Cell Lung Cancer Metastatic - Small Cell Lung Carcinoma
5 Locations available
- Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma
Conditions: Squamous Cell Carcinoma of the Oropharynx
2 Locations available
- Erlotinib Hydrochloride and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery
Conditions: Squamous Cell Carcinoma of the Skin - Stage I Squamous Cell Carcinoma of the Hypopharynx - Stage I Squamous Cell Carcinoma of the Larynx - Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity - Stage I Squamous Cell Carcinoma of the Oropharynx - Sta
1 Location available
- A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer
Conditions: Small Cell Lung Carcinoma
7 Locations available
- Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Conditions: Head and Neck Cancer
1 Location available
- Interleukin-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Treating Patients With Merkel Cell Cancer
Conditions: Recurrent Neuroendocrine Carcinoma of the Skin - Stage I Neuroendocrine Carcinoma of the Skin - Stage II Neuroendocrine Carcinoma of the Skin - Stage III Neuroendocrine Carcinoma of the Skin - Stage IV Neuroendocrine Carcinoma of the Skin
1 Location available
- BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)
Conditions: Renal Cancer
1 Location available
- Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
1 Location available
- BKM120 in Metastatic Transitional Cell Carcinoma of the Urothelium
Conditions: Metastatic Transitional Cell Carcinoma of the Urothelium
5 Locations available
- The Effect of Vitamin D Repletion in Patients With Hepatocellular Carcinoma on the Orthotopic Liver Transplant List
Conditions: Vitamin D Deficiency - Hepatocellular Carcinoma
1 Location available
- Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung - Non-Small Cell Lung Cancer
1 Location available
- A Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies
Conditions: Advanced Nonhematologic Malignancies - Carcinoma, Basal Cell
2 Locations available
- Tesetaxel for Previously Treated Patients With Bladder Cancer
Conditions: Carcinoma, Transitional Cell
2 Locations available
- Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy
Conditions: Kidney Cancer
1 Location available
- Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
Conditions: Squamous Cell Carcinoma of the Head and Neck - Human Papilloma Virus
1 Location available
- Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma
4 Locations available
|